MediFind found 37 doctor with experience in Testicular Cancer near Columbia, MD. Of these, 32 are Experienced and 5 are Advanced.
Maryland Oncology Hematology
As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant.
Maryland Oncology Hematology
Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia.
Maryland Oncology Hematology PA
Ari Elman is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Elman has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Myelodysplastic Syndrome (MDS). Dr. Elman is currently accepting new patients.
Maryland Oncology Hematology PA
Stuart Selonick is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Selonick is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Idiopathic Neutropenia, and Lung Cancer. Dr. Selonick is currently accepting new patients.
Maryland Oncology Hematology PA
Jason Taksey is an Oncologist and a Hematologist in Columbia, Maryland. Dr. Taksey is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Urothelial Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and WT1-Related Wilms Tumor Syndromes. Dr. Taksey is currently accepting new patients.
Maryland Oncology Hematology PA
Nicholas Demonaco is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Demonaco is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Pulmonary Embolism, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Anemia. Dr. Demonaco is currently accepting new patients.
Maryland Oncology Hematology PA
Peter Graze is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Graze is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, and Non-Small Cell Lung Cancer (NSCLC). Dr. Graze is currently accepting new patients.
Chesapeake Urology Associates LLC
Geoffrey Sklar is an Urologist in Fulton, Maryland. Dr. Sklar is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Penile Cancer, Urothelial Cancer, Bladder Cancer, Reconstructive Urology Surgery, and Ureteroscopy. Dr. Sklar is currently accepting new patients.
Johns Hopkins Outpatient Center
Dr. Bass attended Duke University for college and medical school, and received residency training in internal medicine and an MPH degree from the University of Pittsburgh. He completed a fellowship in general internal medicine at Johns Hopkins, and joined the Johns Hopkins faculty in 1989. His strongest research interests are in evidence-based medicine and assessment of the effectiveness, safety, and costs of medical and surgical management strategies. He has been the Director of the Johns Hopkins Evidence-based Practice Center since 2001. His teaching activities focus on medical student education at the interface between medicine and public health. He is the Director of the medical school's course on Foundations of Public Health, and Co-Director of the medical school's Scholarly Concentration in Public Health Research. He was the Director of the General Internal Medicine Fellowship at Johns Hopkins for 15 years. He served as the Editor of the Journal of General Internal Medicine for 5 years, and was the founding Editor-in-Chief of a journal dedicated to community-based participatory research called Progress in Community Health Partnerships. He has been the CEO of the Society of General Internal Medicine since 2017. He has published more than 250 peer-reviewed articles and over 50 evidence reports. He continues to have a clinical practice as a general internist. Dr. Bass is rated as an Advanced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Testicular Cancer, Varicose Veins, Type 2 Diabetes (T2D), Leydig Cell Testicular Tumor, and Orchiectomy.
Skip Viragh Outpatient Cancer Center
William Houck is an Oncologist in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).
Johns Hopkins Outpatient Center
Dr. Noah Hahn is a medical oncologist in the Baltimore area, caring for patients with bladder cancer. He serves as the deputy director of the Greenberg Bladder Cancer Institute at the Johns Hopkins School of Medicine. Dr. Hahn earned his M.D. from Indiana University School of Medicine. He completed his residency in internal medicine at Duke University School of Medicine and performed a fellowship in medical oncology at Indiana University School of Medicine. Dr. Hahn joined the Johns Hopkins faculty in 2014. Prior to joining Johns Hopkins, Dr. Hahn was the director of the Genitourinary Medical Oncology Program at Indiana University and chief scientific officer for the Hoosier Oncology Group, a cancer research organization that evaluates innovative and promising approaches to cancer treatment. He is currently conducting clinical trials to test new therapies for bladder cancer, including those for early stage bladder cancer. Dr. Hahn is a member of the Bladder Cancer Task Force for the National Cancer Institute’s Genitourinary Cancer Steering Committee and is chair of the Bladder Cancer Subcommittee of the Eastern Cooperative Oncology Group. Dr. Hahn is rated as an Advanced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Nephrectomy.
Skip Viragh Outpatient Cancer Center
I am medical oncologist dedicated to the care of patients with genitourinary malignancies. My clinical and research focus is on the management of renal cell carcinoma (RCC). I have completed Medical Oncology Higher Specialist Training with Royal College of Physicians in Ireland and subsequently completed Advanced Medical Oncology Fellowship at the Memorial Sloan Kettering Cancer Center in New York. Dr. Ged is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, Nephrectomy, and Thrombectomy.
Rubenstein Child Health Building
Dr. Heather Noelle Di Carlo is an associate professor of urology at the Johns Hopkins University School of Medicine. She treats all pediatric urological disorders in young males and females while specializing in renal sparing surgery and complex reconstruction of the genitourinary tract in patients with the exstrophy-epispadias complex, disorders of sexual development (DSD) and other congenital anomalies. She serves as the Director of Pediatric Urology Research and is the interim Division Director of Pediatric Urology. A native of New York, Dr. Di Carlo graduated from Emory University with a B.S. in neuroscience and music, and the State University of New York at Stony Brook School of Medicine. Following general surgery and urology residency training at Stony Brook Medical Center, she completed a pediatric urology fellowship at the James Buchanan Brady Urological Institute. Dr. Di Carlo has special clinical and basic science interests in the exstrophy-epispadias complex, spina bifida and renal transplantation. Dr. Di Carlo is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. Her top areas of expertise are Exstrophy of the Bladder, Exstrophy-Epispadias Complex, Cloacal Exstrophy, Bladder Reconstruction, and Osteotomy.
Johns Hopkins Outpatient Center
Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. Dr. Kates is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.
Skip Viragh Outpatient Cancer Center
Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer. Dr. Hoffman is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. Her top areas of expertise are Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Bladder Reconstruction.
Johns Hopkins Outpatient Center
Karan Rao is an Interventional Radiologist in Baltimore, Maryland. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Testicular Torsion, Stroke, Osteoarthritis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.
Maryland Oncology Hematology PA
Kashif Ali is a Hematologist Oncology specialist and a Hematologist in Laurel, Maryland. Dr. Ali is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Iron Deficiency Anemia, Agranulocytosis, Chronic Familial Neutropenia, and Childhood Iron Deficiency Anemia. Dr. Ali is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Elias is a medical oncologist and physician scientist specializing in the treatment of genitourinary (kidney, prostate, bladder) cancers. Dr. Elias received his medical degree from the University of Miami Medical School. He completed his residency in Internal Medicine at the University of Texas Southwestern in Dallas, TX. He went on to complete a fellowship in Medical Oncology at Johns Hopkins in Baltimore MD. Dr. Elias’ laboratory is focused on the development of biomarkers and novel therapeutics for genitourinary malignancies. Dr. Elias is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Testicular Yolk Sac Tumor, Testicular Cancer, Acute Promyelocytic Leukemia, and Nephrectomy.
University Of Maryland Oncology Associates PA
Heather Mannuel is an Oncologist and a Hematologist in Baltimore, Maryland. Dr. Mannuel is rated as an Advanced provider by MediFind in the treatment of Testicular Cancer. Her top areas of expertise are WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Prostate Cancer, and Renal Cell Carcinoma (RCC). Dr. Mannuel is currently accepting new patients.
Medstar Medical Group Ii LLC
Ankit Madan is a Hematologist Oncology specialist and a Hematologist in Olney, Maryland. Dr. Madan has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Testicular Cancer. His top areas of expertise are Colorectal Cancer, Lynch Syndrome, Familial Colorectal Cancer, and Inflammatory Breast Cancer. Dr. Madan is currently accepting new patients.
Last Updated: 01/09/2026









